Yesafili, available in vial and prefilled syringe presentations (2 mg/0.05 mL), was the first biosimilar to Eylea approved by Health Canada
Everolimus TFOS is a kinase inhibitor indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
WINLEVI works differently from any other topical acne treatment
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
